FDA Recalls Tirzepatide Injectable Due to Sterility Concerns
Carolina Infusion, LLC is recalling Tirzepatide 26 mg/mL injectable syringes due to a lack of assurance of sterility related to formulation and processing equipment.
- Product
- TIRZEPATIDE 26 MG/ML INJECTABLE, Packaged in single-use dosage syringes, total mL dispensed based on dosage per specific patient prescription, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936;
- Category
- Drug
- Distribution
- Distributed nationwide